Literature DB >> 6098937

Cooperativity of thymopoietin 32-36 (the active site) and thymopoietin 38-45 in receptor binding.

T Audhya, G A Heavner, D J Kroon, G Goldstein.   

Abstract

Thymopoietin is a 49 amino acid polypeptide hormone of the thymus whose biological activity is reproduced by the synthetic pentapeptide thymopentin, corresponding to amino acids 32-36. Thymopentin requires the addition of an octapeptide corresponding to thymopoietin 38-45 for full competition with native thymopoietin in a radioreceptor assay with receptor derived from the human T-cell line CEM. Thus thymopoietin appears to bind to its receptor on T-cells by two regions (32-36 and 38-45). Thymopentin alone is biologically active and induces elevations of intracellular cyclic GMP. Whilst occupancy of the adjacent site by thymopoietin 37-45 does not of itself cause an elevation of intracellular cyclic GMP this peptide is not biologically silent as it does enhance the potency of thymopentin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6098937     DOI: 10.1016/0167-0115(84)90068-5

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  3 in total

Review 1.  Immunomodulation with thymopentin: in vitro studies.

Authors:  J Duchateau; K Bolla
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

Review 2.  Thymopoietin, a thymic polypeptide, potently interacts at muscle and neuronal nicotinic alpha-bungarotoxin receptors.

Authors:  M Quik
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

Review 3.  Peptides: Prospects for Use in the Treatment of COVID-19.

Authors:  Vladimir Khavinson; Natalia Linkova; Anastasiia Dyatlova; Boris Kuznik; Roman Umnov
Journal:  Molecules       Date:  2020-09-24       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.